Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P235: Endoscopic, clinical, and surgical recurrence of Crohn's disease: In which direction are we going?ECCO '17 Barcelona
Year: 2017
Authors:

Campanati L., Indriolo A., Giulii Capponi M., Panyor G., Lotti M., Rubertà F., Giussani M., Poiasina E., Cosimo P., Ansaloni L., Ravelli P.

Papa Giovanni XXIII Hospital, Bergamo, Italy

P236: Fecal calprotectin as suitable biomarker in evaluation of histological disease activityECCO '17 Barcelona
Year: 2017
Authors:

Knezevic Ivanovski T.*1, Knezevic Usaj S.2, Gligorijevic V.1, Markovic S.1, Svorcan P.1, Nedeljkovic Protic M.1

1University Hospital Zvezdara, Gastroenterology and hepatology, Belgrade, Serbia 2Institute of Oncology of Vojvodina, Department of Pathology and laboratory diagnostics, Novi Sad, Serbia

P237: Hair mineral and trace element contents as reliable markers of nutritional status compared to serum levels in children with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Yang H.R.*1,2, Cho J.M.1

1Seoul National University Bundang Hospital, Department of Pediatrics, Seongnam, South Korea 2Seoul National University, Department of Pediatrics, Seoul, South Korea

P238: Mental health issues and healthcare utilisation in outpatients with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Lores T.*1, Goess C.1, Hrycek C.2, Grafton R.1, Hughes J.1, Cronin L.1, Mikocka-Walus A.3, Chur-Hansen A.4, Burke A.L.5, Collins K.L.5, Andrews J.M.1

1Royal Adelaide Hospital, Gastroenterology, Adelaide, Australia 2Royal Adelaide Hospital, Department of General Medicine, Adelaide, Australia 3University of York, Heslington, United Kingdom 4University of Adelaide, Adelaide, Australia 5Royal Adelaide Hospital, Psychology, Adelaide, Australia

P239: A novel user friendly model to identify key predictors of corticosteroid utilization in newly diagnosed patients with ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Patel D.*1, Shah Y.2, Khan N.3

1Mercy Catholic, Philadelphia, United States 2VA Medical Center Philadelphia, Philadelphia, United States 3University of Pennsylvania, Philadelphia, United States

P240: Presentation and surgical interventions for Crohn's disease with perianal fistula in the biologics era: results from a multicentre studyECCO '17 Barcelona
Year: 2017
Authors:

Black C.1, Pugliese D.2, Sahnan K.3, Armuzzi A.2, Elkady S.M.3, Hart A.L.3, Katsanos K.H.4, Christodoulou D.K.4, Selinger C.5, Maconi G.6, Fiorino G.7, Davidov Y.8, Kopylov U.8, Ben-Horin S.8, Navarro P.9, Bosca-Watts M.M.9, Muscat M.10, Ellul P.10, Karmiris K.11, Allgar V.12, Danese S.7, Fearnhead N.S.13, Sebastian S.*1,14

1Hull & East Yorkshire NHS Trust, IBD Unit, Hull, United Kingdom 2Gemelli Hospital Catholic University, Rome, Italy 3St Marks Hospital, London, United Kingdom 4University of Ioannina, Ioannina, Greece 5Leeds Teaching hospitals NHS Trust, Leeds, United Kingdom 6Louigi Sacco University Hospital, Milan, Italy 7Humanitas Research Hospital, Milan, Italy 8Sheba Medical Center, Tel-Aviv, Israel 9University Clinic Hospital, Valencia, Spain 10Mater Dei Hospital, Msida, Malta 11Venizeleio General Hospital, Crete, Greece 12University of York, York, United Kingdom 13Addenbrooks University Hospitals, Cambridge, United Kingdom 14Hull & East Yorkshire NHS Trust, Hull, United Kingdom

P241: Defining patient-centered outcomes for IBD – an international, cross-disciplinary consensusECCO '17 Barcelona
Year: 2017
Authors:

Kim A.*1, Roberts C.2, Feagan B.3, Banerjee R.4, Bemelman W.5, Bodger K.6,7, Derieppe M.8, Dignass A.9, Driscoll R.10, Fitzpatrick R.11, Higgins P.12, Kotze P.13, Meissner J.14, O'Connor M.15, Ran Z.-H.16, Siegel C.17, Terry H.18, van Deen W.19,20, van der Woude C.21, Weaver A.14, Yang S.-K.22, Sands B.23, Vermeire S.24, Travis S.1

1Translational Gastroenterology Unit, Oxford, United Kingdom 2International Consortium for Health Outcomes Measurement, London, United Kingdom 3University of Western Ontario, Department of Medicine, London, Canada 4Asian Institute of Gastroenterology, Hyderabad, India 5Academic Medical Center, Department of Surgery, Amsterdam, Netherlands 6Institute of Translational Medicine, University of Liverpool, Department of Gastroenterology, Liverpool, United Kingdom 7UK Digestive Diseases Centre, Aintree University Hospitals NHS Trust, Liverpool, United Kingdom 8Association François Aupetit, Paris, France 9Agaplesion Markus Hospital, Goethe-University, Department of Medicine I, Frankfurt am Main, Germany 10Health Quality Improvement Partnership, London, United Kingdom 11University of Oxford, Oxford, United Kingdom 12University of Michigan Medical School, Department of Internal Medicine, Michigan, United States 13Catholic University of Parana, Curitiba, Brazil 14Crohn's and Colitis Foundation of America, New York, United States 15St Mark's Hospital, London Northwest Healthcare NHS Trust, London, United Kingdom 16Ren Ji Hospital, Shanghai Jiatong University, Department of Gastroenterology, School of Medicine, Shanghai, China 17Dartmouth-Hitchcock Medical Center, Department of Gastroenterology, Lebanon, United States 18Crohn's and Colitis UK, St Albans, United Kingdom 19UCLA Center for Inflammatory Bowel Diseases, Los Angeles, United States 20USC Gehr Family Center for Implementation Science, Los Angeles, United States 21Erasmus University Medical Centre, Rotterdam, Netherlands 22University of Ulsan College of Medicine, Asan Medical Center, Department of Gastroenterology, Seoul, South Korea 23Icahn School of Medicine at Mount Sinai, New York, United States 24University Hospitals Leuven, Department of Gastroenterology & Hepatology, Leuven, Belgium

P242: Phenotypic characterisation of elderly – onset inflammatory bowel disease – IBD at the extremesECCO '17 Barcelona
Year: 2017
Authors:

Nosegbe U.*1, Scott J.A.2, Crooks B.2, Miller B.2, Limdi J.2,3

1The Pennine Acute Hospitals NHS Trust, Manchester UK, Gastroenterology Dept, Bury, United Kingdom 2The Pennine Acute Hospitals NHS Trust, Manchester, United Kingdom 3University of Manchester, Institute of Inflammation and Repair, Manchester Academic Health Sciences Centre, Manchester, United Kingdom

P243: Complications of newly diagnosed Crohn's disease can be predicted by mathematical modeling of serologic responsesECCO '17 Barcelona
Year: 2017
Authors:

Yanai H.*1,2, Ben-Shachar S.2,3, Maharshak N.1,2, Ron Y.1,2, Leshno M.2,4, Dotan I.1,2

1Tel Aviv Sourasky Medical Center, IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel 2Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel 3Tel Aviv Sourasky Medical Center, Genetic Institute, Tel Aviv, Israel 4Tel Aviv University, Coller School of Management, Tel Aviv, Israel

P244: Diffusion-weighted MRI enables to accurately grade inflammatory activity in patients of ileocolonic Crohn's disease: results from an observational studyECCO '17 Barcelona
Year: 2017
Authors:

Mao R.1, Li X.2, Li Z.2, Chen M.*1

1The first affiliated hospital of Sun Yat-Sen University, Department of Gastroenterology, Guangzhou, China 2The first affiliated hospital of Sun Yat-Sen University, Department of Radiology, Guangzhou, China

P245: A systematic review of outcomes reported in studies on fistulising perianal Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Sahnan K.*1, Adegbola S.O.1, Tozer P.J.1, Allin B.S.R.2, Lee M.J.3, Heywood N.4, McNair A.G.K.5, Lobo A.J.6, Brown S.R.3, Sebastian S.7, Phillips R.K.1, Lung P.F.8, Faiz O.D.1, Blackwell S.9, Verjee A.10, Fearnhead N.S.11, Hart A.L.12

1St Mark's Hospital, Colorectal Surgery, London, United Kingdom 2Oxford University, National Perinatal Epidemiology Unit, Oxford, United Kingdom 3Sheffield Teaching Hospitals NHS Trust, Northern General Hospital, Department of Colorectal Surgery, Sheffield, United Kingdom 4University Hospital South Manchester, Department of Colorectal Surgery, Manchester, United Kingdom 5Bristol, School of Social and Community Medicine, Bristol, United Kingdom 6Sheffield Teaching Hospitals NHS Trust, Northern General Hospital, Department of Gastroenterology, Sheffield, United Kingdom 7Hull Royal Infirmary, Hull & East Yorkshire Hospitals NHS Trust, Department of Gastroenterology and Hepatology, Hull, United Kingdom 8St Mark's Hospital, Gastrointestinal Imaging, London, United Kingdom 9Patient representative, Liverpool, United Kingdom 10Patient representative, London, United Kingdom 11Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Department of Colorectal Surgery, Cambridge, United Kingdom 12St Mark's Hospital, IBD/Physiology, London, United Kingdom

P246: Risk factors associated with low ovarian reserve in young women of reproductive age with Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Mao R.1, Zhao Y.1, He Y.1, Ben-Horin S.2, Chen M.-h.*1

1First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China 2Sheba Medical Center, Tel-aviv, Israel

P247: Fungal infections in children with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Majorová E.*1, Šusterová I.2, Kolarčik P.3, Fandakova I.4, Majlingová S.1, Gombošová K.1, Petrášová M.1

1Detská fakultná nemocnica, Paediatric Department, Košice, Slovakia 2Faculty of Medicine P.J.Šafarik University, Paediatric Department, Košice, Slovakia 3Faculty of Medicine P.J.Šafarik University, Department of Health Psychology, Košice, Slovakia 4Synlab Slovakia, Košice, Slovakia

P248: The new infliximab point-of-care quantitative test can equally be used for therapeutic drug monitoring of biosimilars of infliximabECCO '17 Barcelona
Year: 2017
Authors:

Afonso J.*1,2, Sousa H.T.3, Rosa I.4, Carvalho J.5, Dias C.C.6,7, Magro F.1,2,8

1Faculty of Medicine, University of Porto, Department of Biomedicine, Unit of Pharmacology and Therapeutics, Porto, Portugal 2Centre for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal 3Centro Hospitalar do Algarve, Gastroenterology Department, Portimão, Portugal 4Instituto Português de Oncologia de Lisboa, Gastroenterology Department, Lisboa, Portugal 5Centro Hospitalar de Gaia, Department of Gastroenterology and Hepatology, Vila Nova de Gaia, Portugal 6Center for Health Technology and Services Research, Porto, Portugal 7Faculty of Medicine, University of Porto, Health Information and Decision Sciences Department, Porto, Portugal 8Centro Hospitalar São João, Gastroenterology Department, Porto, Portugal

P249: Usefulness of abdominal ultrasonography for patency assessment using the patency capsuleECCO '17 Barcelona
Year: 2017
Authors:

Ishii M.*1, Nasuno M.2, Tanaka H.2, Motoya S.2, Miyakawa M.2, Sugiyama K.2, Honda K.3, Matsumoto H.1, Fujita M.1, Manabe N.4, Hata J.4, Shiotani A.1

1Kawasaki Medical School, Division of Gastroenterology Department of Internal Medicine, Kurashiki, Japan 2Sapporo Kosei General Hospital, IBD Center, Sapporo, Japan 3Kawasaki Medical School, Genaral Medicine, Kurashiki, Japan 4Kawasaki Medical School, Clinical Pathology and Laboratory Medicine, Kurashiki, Japan

P250: DUBLIN (Degree of Ulcerative Colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Rowan C.R.*1, Twomey P.2, Cullen G.1,2, Sheridan J.1,2, Mulcahy H.1,2, Ryan E.2, Doherty G.A.1,2

1St Vincent's University Hospital, Centre for Colorectal Disease, Dublin, Ireland 2University College Dublin, School of Medicine, Dublin, Ireland

P251: The contribution of clinical and psychosocial factors to fatigue in 182 patients with inflammatory bowel disease: a cross-sectional studyECCO '17 Barcelona
Year: 2017
Authors:

Artom M., Czuber-Dochan W., Sturt J., Murrells T., Norton C.

King's College London, Florence Nightingale Faculty of Nursing & Midwifery, London, United Kingdom

P252: Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Oh K.*1, Oh E.H.1, Song E.M.2, Kim G.-U.2, Seo M.2, Hwang S.W.2,3, Park S.H.2,3, Yang D.-H.2, Kim K.-J.2,3, Byeon J.-S.2, Myung S.-J.2, Yang S.-K.2,3, Ye B.D.2,3

1University of Ulsan College of Medicine, Asan Medical Center, Internal Medicine, Seoul, South Korea 2University of Ulsan College of Medicine, Asan Medical Center, Gastroenterology, Seoul, South Korea 3University of Ulsan College of Medicine, Asan Medical Center, Inflammatory Bowel Disease Center, Seoul, South Korea

P253: Effects of time on urinary metabolic signatures in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Hicks L.*1, Powles S.1, Swann J.2, Chong L.1, Holmes E.2, Williams H.1, Orchard T.1

1Imperial College Healthcare NHS Trust St. Mary's Hospital, Department of Gastroenterology, London, United Kingdom 2Imperial College London, Computational and Systems Medicine, London, United Kingdom

P254: Relationship between severe endoscopic lesions and plasmatic and fecal infliximab levels in acute severe ulcerative colitis: a case control studyECCO '17 Barcelona
Year: 2017
Authors:

Poullenot F.*1, Nivet D.2, Paul S.3, Ricard J.1, Roblin X.4, Laharie D.1

1CHU Bordeaux, Department of Gastroenterology, Bordeaux, France 2CHCB, Gastroenterology, Bayonne, France 3CHU Saint-Etienne, Immunology, Saint-Etienne, France 4CHU Saint-Etienne, Gastroenterology, Saint-Etienne, France